Who Should Not Take L-Carnitine: Contraindications and Cautions
L-carnitine is marketed as a fat burner, an endurance aid and a recovery supplement, and it is generally considered safe for healthy adults. "Generally safe" is not the same as "safe for everyone," though. Our editorial team gathered what is known about the people who should avoid L-carnitine or use it only with a doctor's involvement.
A quick refresher on L-carnitine
L-carnitine is a compound synthesized in the liver and kidneys from the amino acids lysine and methionine. Its best-known role is shuttling long-chain fatty acids into mitochondria, where they are oxidized for energy. It also helps remove excess acyl groups from cells, which is important in some inherited metabolic disorders.
Healthy people produce enough carnitine on their own, and red meat and dairy add more. Vegans have lower dietary intake but usually maintain normal blood levels thanks to endogenous production and efficient kidney reabsorption.
In the United States, levocarnitine is both a prescription drug, used for primary and secondary carnitine deficiency including in some dialysis patients, and a widely sold dietary supplement. Supplement forms include L-carnitine base, L-carnitine L-tartrate, acetyl-L-carnitine and propionyl-L-carnitine.
Evidence for fat loss in healthy, non-deficient people is weak. Research by Wall and colleagues (2011) showed that muscle carnitine only rises meaningfully when supplementation is combined with large amounts of carbohydrate for months, which limits practical appeal. Recovery benefits, reviewed by Fielding and colleagues (2018), are more promising but modest.
Thyroid conditions
One of the less obvious cautions concerns the thyroid. L-carnitine appears to act as a peripheral antagonist of thyroid hormone, reducing its entry into cell nuclei. A randomized trial by Benvenga and colleagues (2001) actually used L-carnitine to relieve symptoms of iatrogenic hyperthyroidism.
That property is potentially useful in people with excess thyroid hormone, but it raises a concern for people with hypothyroidism. In theory, high-dose L-carnitine could blunt the effect of thyroid hormone replacement and worsen symptoms such as fatigue and cold intolerance.
Clinical data in hypothyroid patients taking supplement doses are limited, so this is a precautionary rather than a proven contraindication. Still, anyone on levothyroxine who decides to use L-carnitine should inform their doctor and consider checking thyroid labs after starting.
The same applies to people with thyroid disease that is not yet well controlled. Adding a compound that interferes with hormone action makes dose adjustments more difficult to interpret.
Seizure disorders and blood thinners
There are case reports and anecdotal observations of increased seizure frequency in people with epilepsy after starting L-carnitine or its derivatives. The evidence is weak and the mechanism unclear, but many reference sources list a history of seizures as a reason for caution.
Interestingly, carnitine is sometimes prescribed to people with epilepsy taking valproic acid, a drug that can deplete carnitine. In those cases it is given under medical supervision for a specific reason. The caution is about self-supplementation without that context.
The second notable interaction involves oral anticoagulants. Case reports, including one by Bachmann and Hoffmann (2004), describe increases in INR, a measure of blood clotting time, when L-carnitine was added to acenocoumarol. Similar concerns have been raised for warfarin, the vitamin K antagonist most used in the US.
| Group | Concern | Strength of evidence | Recommendation |
|---|---|---|---|
| Hypothyroidism | May blunt thyroid hormone action | Mechanistic and clinical in hyperthyroidism | Discuss with doctor, monitor labs |
| Seizure history | Possible increase in seizures | Case reports | Avoid unless prescribed |
| Warfarin and similar drugs | Higher INR, bleeding risk | Case reports | Avoid or monitor INR closely |
| Kidney disease (not on dialysis) | Accumulation of metabolites | Pharmacological reasoning | Only under nephrologist care |
| Pregnancy and breastfeeding | Insufficient safety data | Lack of studies | Avoid unless prescribed |
Because changes in INR can lead to dangerous bleeding, people on vitamin K antagonists should not start or stop L-carnitine without informing the clinic that manages their anticoagulation.
Kidney disease, TMAO and heart health
The kidneys regulate carnitine levels and clear its metabolites. In people with chronic kidney disease who are not on dialysis, supplemental carnitine and its breakdown products may accumulate. This group should use carnitine only when a nephrologist recommends it. Dialysis patients, paradoxically, may lose carnitine and sometimes receive it as prescribed therapy.
A more debated topic is trimethylamine N-oxide (TMAO). Gut bacteria convert part of oral L-carnitine into trimethylamine, which the liver oxidizes to TMAO. A study by Koeth and colleagues (2013) in Nature Medicine linked carnitine, TMAO and accelerated atherosclerosis in mice, and higher TMAO has been associated with cardiovascular events in human observational studies.
Whether supplement-induced increases in TMAO actually raise cardiovascular risk in humans is not settled. TMAO is also high after eating fish, which is linked to better heart health, and causality has not been proven. Nevertheless, people with established coronary disease or high cardiovascular risk may reasonably choose to avoid long-term high-dose supplementation.
A risk assessment by Hathcock and Shao (2006) suggested an observed safe level of about 2 g per day for chronic intake in healthy adults. Higher amounts are more likely to cause side effects such as nausea, diarrhea and a fishy body odor caused by trimethylamine.
Other groups and practical precautions
Several further groups should be careful or seek medical advice before using L-carnitine:
- Pregnant and breastfeeding women, because safety data for supplemental doses are insufficient.
- Children and teenagers, unless carnitine is prescribed for a diagnosed condition.
- People with severe liver disease, who may process carnitine and its metabolites differently.
- People with trimethylaminuria, a genetic condition in which body odor worsens with carnitine intake.
- Anyone taking several prescription medications, where unexpected interactions are harder to rule out.
Avoid products containing D-carnitine or a racemic DL-carnitine mixture. The D form is biologically inactive and may compete with L-carnitine, potentially causing deficiency symptoms.
For healthy adults who do decide to use L-carnitine, doses studied for recovery are typically 1–2 g per day of L-carnitine L-tartrate or equivalent. Choosing products verified by third-party testing helps ensure the label reflects reality.
Conclusions of the editorial team
L-carnitine is well tolerated by most healthy adults, but it is not appropriate for everyone. Thyroid disease, seizure disorders, oral anticoagulants and kidney disease are the main reasons for caution.
The TMAO question remains open; people with cardiovascular disease may prefer to avoid long-term high doses until the evidence is clearer.
For more context, we recommend our articles on acetyl-L-carnitine and cognition, on supplements that interact with blood thinners, and on evidence-based approaches to fat loss.
References
- Benvenga S, Ruggeri RM, Russo A, et al. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2001;86(8):3579–3594.
- Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–585.
- Hathcock JN, Shao A. Risk assessment for carnitine. Regul Toxicol Pharmacol. 2006;46(1):23–28.
- Wall BT, Stephens FB, Constantin-Teodosiu D, et al. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol. 2011;589(Pt 4):963–973.
- Fielding R, Riede L, Lugo JP, Bellamine A. L-Carnitine supplementation in recovery after exercise. Nutrients. 2018;10(3):349.
- Bachmann HU, Hoffmann A. Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol. Swiss Med Wkly. 2004;134(25-26):385.
